Deutsche Bank’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.88M Buy
1,158,138
+33,149
+3% +$128K ﹤0.01% 1397
2026
Q1
$3.95M Buy
1,124,989
+15,065
+1% +$61.7K ﹤0.01% 1423
2025
Q4
$3.74M Sell
1,109,924
-417,305
-27% -$1.08M ﹤0.01% 1454
2025
Q3
$2M Buy
1,527,229
+3,892
+0.3% +$4.03K ﹤0.01% 1773
2025
Q2
$1.1M Sell
1,523,337
-30,817
-2% -$24.2K ﹤0.01% 2042
2025
Q1
$2.28M Sell
1,554,154
-13,381
-0.9% -$31.9K ﹤0.01% 1661
2024
Q4
$6.94M Buy
1,567,535
+504,336
+47% +$2.05M ﹤0.01% 1174
2024
Q3
$4.38M Buy
1,063,199
+16,062
+2% +$86.4K ﹤0.01% 1332
2024
Q2
$6.83M Sell
1,047,137
-470,589
-31% -$3.33M ﹤0.01% 1132
2024
Q1
$13.2M Buy
1,517,726
+1,064,001
+235% +$12.9M 0.01% 946
2023
Q4
$5.19M Buy
453,725
+379,558
+512% +$3.75M ﹤0.01% 1242
2023
Q3
$714K Sell
74,167
-1,489,417
-95% -$14.6M ﹤0.01% 1932
2023
Q2
$16.6M Buy
1,563,584
+359,623
+30% +$3.87M 0.01% 841
2023
Q1
$12.7M Buy
1,203,961
+924,050
+330% +$10.4M 0.01% 888
2022
Q4
$3.47M Sell
279,911
-637,171
-69% -$7.23M ﹤0.01% 1370
2022
Q3
$9.5M Sell
917,082
-2,525,668
-73% -$28.6M 0.01% 972
2022
Q2
$39.7M Buy
3,442,750
+2,770,309
+412% +$32.6M 0.02% 584
2022
Q1
$8.46M Buy
672,441
+263,859
+65% +$3.02M ﹤0.01% 1163
2021
Q4
$4.76M Buy
408,582
+1,088
+0.3% +$13.3K ﹤0.01% 1465
2021
Q3
$5.32M Buy
407,494
+307,728
+308% +$3.98M ﹤0.01% 1470
2021
Q2
$1.28M Sell
99,766
-647,446
-87% -$7.41M ﹤0.01% 2614
2021
Q1
$8.35M Buy
747,212
+604,943
+425% +$6.39M ﹤0.01% 1285
2020
Q4
$1.62M Sell
142,269
-16,096
-10% -$176K ﹤0.01% 2082
2020
Q3
$1.43M Sell
158,365
-344,138
-68% -$3.42M ﹤0.01% 1952
2020
Q2
$5.19M Buy
502,503
+319,830
+175% +$3.27M ﹤0.01% 1286
2020
Q1
$1.84M Sell
182,673
-1,014,924
-85% -$11.9M ﹤0.01% 1757
2019
Q4
$15.9M Buy
1,197,597
+626,307
+110% +$6.91M 0.01% 874
2019
Q3
$4.9M Sell
571,290
-45,212
-7% -$439K ﹤0.01% 1415
2019
Q2
$6.74M Sell
616,502
-334,166
-35% -$3.74M ﹤0.01% 1616
2019
Q1
$10.8M Buy
950,668
+866,235
+1,026% +$9.67M 0.01% 1331
2018
Q4
$730K Sell
84,433
-516,580
-86% -$5.93M ﹤0.01% 3085
2018
Q3
$9.29M Buy
601,013
+185,906
+45% +$2.94M ﹤0.01% 1699
2018
Q2
$6.65M Sell
415,107
-212,253
-34% -$3.14M ﹤0.01% 2086
2018
Q1
$8.11M Buy
627,360
+236,586
+61% +$2.95M ﹤0.01% 1801
2017
Q4
$4.9M Sell
390,774
-1,668,129
-81% -$21.8M ﹤0.01% 2042
2017
Q3
$27.2M Buy
2,058,903
+1,156,092
+128% +$15.9M 0.02% 842
2017
Q2
$14.3M Buy
902,811
+537,415
+147% +$7.81M 0.01% 1148
2017
Q1
$5.22M Buy
365,396
+114,157
+45% +$1.56M ﹤0.01% 1652
2016
Q4
$3.22M Sell
251,239
-212,666
-46% -$2.69M ﹤0.01% 1955
2016
Q3
$6.17M Sell
463,905
-788,139
-63% -$9.21M ﹤0.01% 1602
2016
Q2
$13.7M Sell
1,252,044
-687,431
-35% -$6.72M 0.01% 1114
2016
Q1
$17.8M Sell
1,939,475
-53,101
-3% -$438K 0.01% 962
2015
Q4
$19.3M Sell
1,992,576
-1,907,169
-49% -$18.4M 0.01% 933
2015
Q3
$34M Sell
3,899,745
-5,132,891
-57% -$47.9M 0.03% 626
2015
Q2
$91.2M Buy
9,032,636
+1,073,572
+13% +$12.5M 0.06% 382
2015
Q1
$107M Sell
7,959,064
-420,664
-5% -$5.52M 0.07% 328
2014
Q4
$108M Buy
8,379,728
+1,978,688
+31% +$22.6M 0.07% 343
2014
Q3
$69.4M Buy
6,401,040
+1,738,952
+37% +$19.9M 0.04% 440
2014
Q2
$59.9M Sell
4,662,088
-2,934,646
-39% -$31.9M 0.04% 472
2014
Q1
$78.4M Buy
7,596,734
+1,832,570
+32% +$20.6M 0.06% 388
2013
Q4
$56M Buy
5,764,164
+1,577,368
+38% +$14.2M 0.04% 459
2013
Q3
$41.5M Buy
4,186,796
+3,720,937
+799% +$36.5M 0.03% 560
2013
Q2
$3.87M Buy
+465,859
New +$5.65M ﹤0.01% 1774

Other funds holding IRWD

Deutsche Bank's IRWD Position: Q2 2026 in Review

Deutsche Bank increased its Ironwood Pharmaceuticals (IRWD) stake by 2.9% in Q2 2026, buying an estimated $128K and bringing the position to 1,158,138 shares worth $4.88M. The position accounts for ﹤0.01% of the portfolio, ranked #1397.

Deutsche Bank first reported a position in IRWD in Q2 2013 and has held it in 53 quarters since. The position peaked at $108M in Q4 2014. 71 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Deutsche Bank held 1,158,138 shares of Ironwood Pharmaceuticals worth $4.88M as of Q2 2026.
  • Deutsche Bank bought 33,149 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $128K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1397 holding.
  • Deutsche Bank first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Deutsche Bank's Ironwood Pharmaceuticals position peaked at $108M in Q4 2014.
  • 71 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.